Transcept Pharmaceuticals' P2P Acquisition

Transcept Pharmaceuticals raised a round of funding on October 31, 2014. Investors include Paratek Pharmaceuticals.

Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuros…

Articles about Transcept Pharmaceuticals' P2P Acquisition: